Clinical Trials Directory

Trials / Completed

CompletedNCT01271348

Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise

Multiple-dose, Randomized, Double Blinded, Placebo-controlled, Cross Over Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
X-pert Med GmbH · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Comparison of the effect of etoricoxib to placebo on muscle pain caused by eccentric contractions

Conditions

Interventions

TypeNameDescription
DRUGEtoricoxibEtoricoxib film tablet, 90 mg, q.d.
DRUGplaceboPlacebo tablet, q.d.

Timeline

Start date
2011-01-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2011-01-06
Last updated
2011-11-01

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01271348. Inclusion in this directory is not an endorsement.

Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise (NCT01271348) · Clinical Trials Directory